(Q74014903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Correlation between different intensities of anti-vitamin K treatment and coagulation parameters (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

A Jerkeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Astermark

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

U Hedner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Lethagen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C G Olsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Berntorp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

467-471

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Assessment of Anticoagulant Treatment of Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Low-dose warfarin decreases coagulability without affecting prothrombin complex activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

Are prothrombin fragment 1 + 2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900203-6

7 January 2021

10.1016/S0049-3848(00)00203-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899345%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference